Cargando…
Evaluating Costs Associated With Genetic Counseling Among Commercially Insured US Patients With Cancer From 2013 to 2019
This cohort study describes the prevalence of out-of-pocket costs for cancer-related genetic counseling services in the US.
Autores principales: | Roberson, Mya L., Padi-Adjirackor, Nana Addo, Hooker, Gillian, Pal, Tuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338408/ https://www.ncbi.nlm.nih.gov/pubmed/35983580 http://dx.doi.org/10.1001/jamahealthforum.2022.2260 |
Ejemplares similares
-
Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013
por: McPherson, Timothy, et al.
Publicado: (2016) -
Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023) -
Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022) -
Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014) -
Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
por: Wallace, Beth I., et al.
Publicado: (2021)